A Small Molecule Stabilizes the Disordered Native State of the Alzheimer's Aβ Peptide

ACS Chem Neurosci. 2022 Jun 15;13(12):1738-1745. doi: 10.1021/acschemneuro.2c00116. Epub 2022 Jun 1.

Abstract

The stabilization of native states of proteins is a powerful drug discovery strategy. It is still unclear, however, whether this approach can be applied to intrinsically disordered proteins. Here, we report a small molecule that stabilizes the native state of the Aβ42 peptide, an intrinsically disordered protein fragment associated with Alzheimer's disease. We show that this stabilization takes place by a disordered binding mechanism, in which both the small molecule and the Aβ42 peptide remain disordered. This disordered binding mechanism involves enthalpically favorable local π-stacking interactions coupled with entropically advantageous global effects. These results indicate that small molecules can stabilize disordered proteins in their native states through transient non-specific interactions that provide enthalpic gain while simultaneously increasing the conformational entropy of the proteins.

Keywords: Alzheimer’s disease; Aβ42 peptide; native state; small molecule.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Alzheimer Disease* / metabolism
  • Amyloid beta-Peptides / metabolism
  • Entropy
  • Humans
  • Intrinsically Disordered Proteins* / metabolism
  • Peptide Fragments / metabolism

Substances

  • Amyloid beta-Peptides
  • Intrinsically Disordered Proteins
  • Peptide Fragments